BR9107294A - Derivados do GP160 e vacinas baseadas no GP160 ou um derivado do mesmo, contendo um adjuvante - Google Patents

Derivados do GP160 e vacinas baseadas no GP160 ou um derivado do mesmo, contendo um adjuvante

Info

Publication number
BR9107294A
BR9107294A BR9107294A BR9107294A BR9107294A BR 9107294 A BR9107294 A BR 9107294A BR 9107294 A BR9107294 A BR 9107294A BR 9107294 A BR9107294 A BR 9107294A BR 9107294 A BR9107294 A BR 9107294A
Authority
BR
Brazil
Prior art keywords
adjuvant
derivative
derivatives
vaccines based
vaccines
Prior art date
Application number
BR9107294A
Other languages
English (en)
Portuguese (pt)
Inventor
Frans Van Wijnendale
Moncef Slaoul
Claudine Bruck
Myrian Francotte
Suzy Kummert
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of BR9107294A publication Critical patent/BR9107294A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9107294A 1991-03-21 1991-10-25 Derivados do GP160 e vacinas baseadas no GP160 ou um derivado do mesmo, contendo um adjuvante BR9107294A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919106048A GB9106048D0 (en) 1991-03-21 1991-03-21 Vaccines
PCT/EP1991/002047 WO1992016556A1 (fr) 1991-03-21 1991-10-25 Derives de gp160 et vaccins a base de gp160 ou d'un de ses derives contenant un adjuvant

Publications (1)

Publication Number Publication Date
BR9107294A true BR9107294A (pt) 1994-06-14

Family

ID=10691984

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9107294A BR9107294A (pt) 1991-03-21 1991-10-25 Derivados do GP160 e vacinas baseadas no GP160 ou um derivado do mesmo, contendo um adjuvante

Country Status (12)

Country Link
CN (1) CN1064891A (fr)
AP (1) AP368A (fr)
BR (1) BR9107294A (fr)
CZ (1) CZ195793A3 (fr)
FI (1) FI934133A0 (fr)
GB (1) GB9106048D0 (fr)
HU (2) HUT67011A (fr)
IL (1) IL99899A0 (fr)
MA (1) MA22381A1 (fr)
SK (1) SK82593A3 (fr)
WO (1) WO1992016556A1 (fr)
YU (1) YU174491A (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
PL178578B1 (pl) * 1993-03-23 2000-05-31 Smithkline Beecham Biolog Zawiesina cząstek 3-0-deacylowanego monofosforylolipidu A i sposób jej wytwarzania oraz kompozycja szczepionki zawierającej antygen w połączeniu z 3-0-deacylowanym monofosforylolipidem A i sposób jej wytwarzania
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
CN1304580C (zh) * 2004-07-09 2007-03-14 楼伟 重组表达人获得性免疫缺陷病毒I型的表面糖蛋白gp160
WO2006011060A2 (fr) * 2004-07-23 2006-02-02 Chiron Srl Polypeptides pour assemblage oligomere d'antigenes
NZ553776A (en) 2004-09-22 2010-05-28 Glaxosmithkline Biolog Sa Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide.
WO2008104803A2 (fr) 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Protéines
EP3118221B1 (fr) 2007-02-26 2019-08-21 Oxford BioTherapeutics Ltd Proteines
AU2010207552A1 (en) 2009-01-21 2011-09-01 Oxford Biotherapeutics Ltd. PTA089 protein
EP2496605A1 (fr) 2009-11-02 2012-09-12 Oxford Biotherapeutics Ltd. Ror1 comme cible thérapeutique et diagnostique
JP6113721B2 (ja) 2011-06-28 2017-04-12 オックスフォード ビオトヘラペウトイクス エルティーディー． 治療標的及び診断標的
GB201213364D0 (en) 2012-07-27 2012-09-12 Glaxosmithkline Biolog Sa Purification process
GB201213652D0 (en) 2012-08-01 2012-09-12 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
GB201302447D0 (en) 2013-02-12 2013-03-27 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
JP2018511655A (ja) 2015-03-20 2018-04-26 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ボルデテラ属に対するワクチン接種における使用のための免疫原性組成物
ES2929054T3 (es) 2016-05-16 2022-11-24 Access To Advanced Health Inst Formulación que contiene un agonista de TLR y métodos de uso
CA3023672A1 (fr) 2016-05-16 2017-11-23 Infectious Disease Research Institute Liposomes pegyles et procedes d'utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein

Also Published As

Publication number Publication date
AP368A (en) 1994-10-28
FI934133A (fi) 1993-09-21
HU9302642D0 (en) 1994-01-28
WO1992016556A1 (fr) 1992-10-01
GB9106048D0 (en) 1991-05-08
AP9100332A0 (en) 1992-01-31
MA22381A1 (fr) 1992-07-01
CZ195793A3 (en) 1994-05-18
YU174491A (sh) 1994-06-10
HUT67011A (en) 1995-01-30
SK82593A3 (en) 1994-01-12
CN1064891A (zh) 1992-09-30
FI934133A0 (fi) 1993-09-21
IL99899A0 (en) 1992-08-18

Similar Documents

Publication Publication Date Title
BR9107294A (pt) Derivados do GP160 e vacinas baseadas no GP160 ou um derivado do mesmo, contendo um adjuvante
NO892083D0 (no) Fremgangsmaate for fremstilling av arylmetylenyl-derivaterav tiazolidinoner, imidazolidinoner og oksazolidinoner.
KR900011476A (ko) 백신 제제
DK0761231T3 (da) Vaccinepræparat indeholdende adjuvanser
NO934723L (no) Nye derivater av taksolanaloger, deres fremstilling og preparater inneholdende derivatene
NO934146D0 (no) Nye derivater av tiopyranopyrrol, deres fremstilling og farmas!ytiske preparater inneholdende forbindelsene
DK272889D0 (da) Vaccine
NO923283D0 (no) 1,4-benzodioksanderivater, fremgangsmaate for fremstillingderav, samt farmasoeytiske preparater som inneholder minstett slikt derivat
NO891866L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO894266D0 (no) Oftalmiske preparater og fremgangsmaate for deres fremstilling.
NO894539D0 (no) Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
DK189788D0 (da) Vaccine
NO914233D0 (no) Fremgangsmaate for fremstilling av muramyldipeptidderivater og influensavaksine som omfatter derivatene
NO892057L (no) Psylliumpreparat, samt fremgangsmaate for fremstilling av det.
NO891151D0 (no) Arylpiperazinylalkoksyderivater av cykliske imider, samt fremgangsmaate for fremstilling derav.
DE68914043D1 (de) Coccidiosis-Vakzin.
NO892494D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO892262D0 (no) Fremgangsmaate for fremstilling av straalingsfoelsom anordning.
NO893826L (no) Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater.
KR930702527A (ko) gp160의 유도체 및 보조약을 함유하는 gp160 또는 그의 유도체를 기재로하는 백신
NO894103L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
DE3862072D1 (de) Verstellvorrichtung eines verdichters.
NO891985D0 (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
NO893565L (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.
NO894697L (no) Penemderivater og fremgangsmaater for deres fremstilling.

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: C07K 14/005 (2006.01), A61K 39/00 (2006.0